Cell therapy for the treatment of tendinopathy - A systematic review on the pre-clinical and clinical evidence

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 6, 2013, Pages 651-666

  Lui, Pauline Po Yee ^a,b   Ng, Sze Wing ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell therapy; Collagenase induced tendon injury; Systematic review; Tendinopathy; Tendinosis

Indexed keywords

COLLAGENASE;

ADIPOSE TISSUE CELL; ARTICLE; BIOMECHANICS; CELL THERAPY; CELL TYPE; DISEASE MODEL; ECHOGRAPHY; EMBRYONIC STEM CELL; EVIDENCE BASED MEDICINE; FIBROBLAST; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEMATOPOIETIC STEM CELL; HUMAN; METHODOLOGY; MONONUCLEAR CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATIENT SAFETY; PERIVASCULAR CELL; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLE SIZE; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TENDINITIS; TENDON CELL; TISSUE REPAIR; TREATMENT OUTCOME;

EID: 84881230787     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.10.004     Document Type: Article

References (49)

1. Kannus P. Tendons - a source of major concern in competitive and recreational athletes. Scand J Med Sci Sports 1997, 7(2):53-54.
2. United States. Bureau of Labor Statistics. Occupational injuries and illnesses - counts, rates and characteristics. Washington, DC: The Bureau, 1995. p. v.
3. Barreira A.P.B., Alves A.L.G., Saito M.E., Amorim R.L., Kohayagawa A., Menarim B.C., et al. Autologous implant of bone marrow mononuclear cells as treatment of induced equine tendinitis. Int J Appl Res Vet Med 2008, 6(1):46-54.
4. Chen J., Yu Q., Wu B., Lin Z., Pavlos N.J., Xu J., et al. Autologous tenocyte therapy for experimental Achilles tendinopathy in a rabbit model. Tissue Eng Part A 2011, 17(15-16):2037-2048.
5. Torricelli P., Fini M., Filardo G., Tschon M., Pischedda M., Pacorini A., et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011, 35(10):1569-1576.
6. Del Bue M., Ricco S., Ramoni R., Conti V., Gnudi G., Grolli S. Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their associations in vitro and in vivo. Vet Res Commun 2008, 32(Suppl.1):S51-S55.
7. Smith R.K. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008, 30(20-22):1752-1758.
8. Pascual-Garrido C., Rolon A., Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int 2012, 2012:953510.
9. Ellera Gomes J.L., da Silva R.C., Silla L.M., Abreu M.R., Pellanda R. Conventional rotator cuff repair complemented by the aid of mononuclear autologous stem cells. Knee Surg Sports Traumatol Arthrosc 2012, 20(2):373-377.
10. Connell D., Datir A., Alyas F., Curtis M. Treatment of lateral epicondylitis using skin-derived tenocytes-like cells. Br J Sports Med 2009, 43(4):293-298.
11. Pacini S., Spinabella S., Trombi L., Fazzi R., Galimberti S., Dini F., et al. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007, 13(12):2949-2955.
12. Crovace A., Lacitignola L., De Siena R., Rossi G., Francioso E. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 2007, 1(Suppl 1):281-283.
13. Godwin E.E., Young N.J., Dudhia J., Beamish I.C., Smith R.K. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012, 44(1):25-32.
14. Obaid H., Connell D. Cell therapy in tendon disorders: what is the current evidence?. Am J Sports Med 2010, 38(10):2123-2132.
15. Maher C.G., Moseley A.M., Sherrington C., Elkins M.R., Herbert R.D. A description of the trials, reviews, and practice guidelines indexed in the PEDro database. Phys Ther 2008, 88(9):1068-1077.
16. Clarke A.W., Alyas F., Morris T., Robertson C.J., Bell J., Connell D.A. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sports Med 2011, 39(3):614-623.
17. Obaid H., Clarke A., Rosenfeld P., Leach C., Connell D. Skin-derived fibroblasts for the treatment of refractory Achilles tendinosis: preliminary short-term results. J Bone Joint Surg Am 2012, 94(3):193-200.
18. De Mattos Carvalho A., Alves A.L.G., de Oliveira P.G.G., Alvarez L.E.C., Amorim R.L., Hussni C.A., et al. Use of adipose tissue-derived mesenchymal stem cells for experimental tendinitis therapy in equines. J Equine Vet Sci 2011, 31:26-34.
19. Nixon A.J., Dahlgren L.A., Haupt J.L., Yeager A.E., Ward D.L. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008, 96(7):928-937.
20. Watts A.E., Yeager A.E., Kopyov O.V., Nixon A.J. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Stem Cell Res Ther 2011, 2(1):4.
21. Schnabel L.V., Lynch M.E., van der Meulen M.C., Yeager A.E., Kornatowski M.A., Nixon A.J. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorumsuperficialis tendons. J Orthop Res 2009, 27(10):1392-1398.
22. Crovace A., Lacitignola L., Francioso E., Rossi G. Histology and immunohistochemistry study of ovine tendon grafted with cBMSCs and BMMNCs after collagenase-induced tendinitis. Vet Comp Orthop Traumatol 2008, 21(4):329-336.
23. Crovace A., Lacitignola L., Rossi G., Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010, 2010:250978.
24. Emrani H., Davies J.E. Umbilical cord perivascular cells: a mesenchymal cell source for treatment of tendon injuries. Open Tissue Eng Regenerative Med J 2011, 4:112-119.
25. de Vos R.J., van Veldhoven P.L., Moen M.H., Weir A., Tol J.L., Maffulli N. Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull 2010, 95:63-77.
26. van der Worp H., Van Den Akker-Scheek I., van Schie H., Zwerver J. ESWT for tendinopathy: technology and clinical implications. Knee Surg Sports Traumatol Arthrosc 2012, 10.1007/s00167-012-2009-3.
27. Hart L. Corticosteroid and other injections in the management of tendinopthies: a review. Clin J Sport Med 2011, 21(6):540-541.
28. Larsson M.E., Kall I., Nilsson-Helander K. Treatment of patellar tendinopathy - a systematic review of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc 2012, 20(8):1632-1646.
29. Ryan J.M., Barry F.P., Murphy J.M., Mahon B.P. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (London) 2005, 2:8.
30. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W., Fitzpatrick L.A., Neel M.D., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97(5):1227-1231.
31. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371(9624):1579-1586.
32. Arinzeh T.L., Peter S.J., Archambault M.P., Van Den Bos C., Gordon S., Kraus K., et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003, 85-A(10):1927-1935.
33. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lympohocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30(1):42-48.
34. Lui P.P., Maffulli N., Rolf C., Smith R.K. What are the validated animal models for tendinopathy?. Scand J Med Sci Sports 2011, 21(1):3-17.
35. 2012[accessed 27.10.12]. http://www.clinicaltrials.gov/.
36. [accessed 27.10.12]. http://www.anzctr.org.au/.
37. Clayton H.M., Schamhardt H.C., Willemen M.A., Lanovaz J.L., Colborne G.R. Kinematics and ground reaction forces in horses with superficial digital flexor tendinitis. Am J Vet Res 2000, 61(2):191-196.
38. Clayton H.M., Schamhardt H.C., Willemen M.A., Lanovaz J.L., Colborne G.R. Net joint moments and joint powers in horses with superficial digital flexor tendinitis. Am J Vet Res 2000, 61(2):197-201.
39. Meershoek L.S., Lanovaz J.L., Schamhardt H.C., Clayton H.M. Calculated forelimb flexor tendon forces in horses with experimentally induced superficial digital flexor tendinitis and the effects of application of heel wedges. Am J Vet Res 2002, 63(3):432-437.
40. Keg P.R., Barneveld A., Schamhardt H.C., Van Den Belt A.J. Clinical and force plate evaluation of the effect of a high plantar nerve block in lameness caused by induced mid-metatarsal tendinitis. Vet Q 1994, 16(Suppl 2):S70-75.
41. Davidson C.J., Ganion L.R., Gehlsen G.M., Verhoestra B., Roepke J.E., Sevier T.L. Rat tendon morphologic and functional changes resulting from soft tissue mobilization. Med Sci Sports Exerc 1997, 29(3):313-319.
42. Messner K., Wei Y., Andersoon B., Gillquist J., Rasanen T. Rat model of Achilles tendon disorder - A pilot study. Cells Tissues Organs 1999, 165(1):30-39.
43. Fu S.C., Chan K.M., Chan L.S., Fong D.T.P., Lui P.P.Y. The use of motion analysis to measure pain-related behaviour in a rat model of degenerative tendon injuries. J Neurosci Methods 2009, 179(2):309-318.
44. Bi Y., Ehirchiou D., Kilts T.M., Inkson C.A., Embree M.C., Sonoyama W., et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007, 13(10):1219-1227.
45. Rui Y.F., Lui P.P., Li G., Fu S.C., Lee Y.W., Chan K.M. Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A 2010, 16(5):1549-1558.
46. Tan Q., Lui P.P., Rui Y.F., Wong Y.M. Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering. Tissue Eng Pt A 2012, 18(7-8):840-851.
47. Caplan A.I. Why are MSCs therapeutic? New data: new insight. J Pathol 2009, 217(2):318-324.
48. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006, 98(5):1076-1084.
49. Park K.S., Kim Y.S., Kim J.H., Choi B., Kim S.H., Tan A.H., et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 2010, 89(5):509-517.